Cefaly vs. gammaCore: Which FDA-Approved Migraine Device Is Right for You?

Cefaly vs. gammaCore: A Head-to-Head Comparison

Both Cefaly and gammaCore are FDA-cleared, portable devices for migraine, but they work in fundamentally different ways. Cefaly stimulates the trigeminal nerve through the forehead, while gammaCore targets the vagus nerve via the neck. Which one is right for you?

Cefaly is cleared for acute and preventative treatment of episodic migraines. It's used daily for prevention (20-minute sessions) and as needed for acute attacks. The electrode on the forehead can be slightly visible. gammaCore is handheld and applied to the neck for 2-minute doses during an attack or as prevention; it's also approved for cluster headaches. Many users find gammaCore's relief faster for breakthrough pain, but it requires a prescription, while Cefaly is available over‑the‑counter.

Cost-wise, Cefaly's device is around $379 with replacement electrodes, while gammaCore may be covered by insurance (with prior authorization) but its self-pay price is higher, around $575 for a starter kit. Ultimately, your choice hinges on nerve target preference, insurance coverage, and whether you need a preventative-only or acute treatment solution. Both have solid clinical backing.